B-Cell CLL/lymphoma 6, Member B (BCL6B) (Middle Region) Peptid
BCL6B
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BCL6B Produkte
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BCL6B antibody (Catalog #: ARP40045_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Synonyme
- BAZF Peptide, ZBTB28 Peptide, ZNF62 Peptide, Bazf Peptide, RGD1563179 Peptide, B-cell CLL/lymphoma 6B Peptide, B cell CLL/lymphoma 6, member B Peptide, B-cell CLL/lymphoma 6, member B Peptide, BCL6B Peptide, Bcl6b Peptide, bcl6b Peptide
- Hintergrund
-
BCL6B acts as a sequence-specific transcriptional repressor in association with BCL6. BCL6B may function in a narrow stage or be related to some events in the early B-cell development.
Alias Symbols: BAZF, ZBTB28, ZNF62
Protein Interaction Partner: BCL6
Protein Size: 480 - Molekulargewicht
- 52 kDa
- Gen-ID
- 255877
- NCBI Accession
- NM_181844, NP_862827
- UniProt
- Q8N143
-
Sie sind hier:
